PinnedInThe Curious ResearchersbyGaston Welisch·Apr 13, 2023AI Oracles: Reimagining the Role of Creative Practitioners in the Age of Generative AI ToolsThe Oracle of Delphi guided the Greeks and Romans through their questions and decisions, from the banal to the world-changing. When faced…
PinnedInThe Curious ResearchersbyGaston Welisch·Feb 17, 2023Postcard to a ghost: Dr. Marie Skłodowska-Curie to Dr. Anja B. SmykowskiHi and welcome. I am Gaston Welisch and I am the editor for a new series of speculative and experimental articles called ‘Postcards to a…
InThe Curious ResearchersbyGaston Welisch·Oct 19, 2023Cooking up a workshop: The analogical framework and a curricular menuA Recipe for Success Through a Delicious Curriculum Crafting Approach
InThe Curious ResearchersbyGaston Welisch·Oct 6, 2023What I Learned from Building 3 AI Apps in 3 Months: The Unexpected, the Emotional and the EthicalIn the past three months, I set myself a challenge to build three AI apps, each with its own purpose and lessons to be learnt. It was a…
InThe Curious ResearchersbyGaston Welisch·Jul 13, 2023Data Poets: AI and the Poetics of SpaceIn AI as with most technologies, time can bring both change and perspective. Since 2020, AI has gone from a tool of intrigue and…
InThe Curious ResearchersbyGaston Welisch·Mar 29, 2023Postcard to a ghost: Miles Davis to Prof. Nicol KeithMiles Davis is one of the most influential figures in jazz and indeed 20th century music. His life and works are widely covered including…
InThe Curious ResearchersbyGaston Welisch·Jan 18, 2023First in Human — Part 5: Learning from treating childhood cancer.By Gaston Welisch & Nicol Keith
InThe Curious ResearchersbyGaston Welisch·Jan 4, 2023First in Human — Part 4: Networks and Stakeholders in Cancer Trials.By Gaston Welisch & Nicol Keith
InThe Curious ResearchersbyGaston Welisch·Dec 13, 2022First in Human — Part 3: Who makes a Cancer Phase 1 Trial happen?By Gaston Welisch & Nicol KeithA response icon1A response icon1
InThe Curious ResearchersbyGaston Welisch·Nov 29, 2022First in Human — Part 2: The Importance of Cancer Phase 1 Trials.By Gaston Welisch & Nicol Keith